Global Blood Therapeutics, Inc. (GBT)

NASDAQ: GBT · IEX Real-Time Price · USD
31.79
+0.86 (2.78%)
At close: Jun 24, 2022 4:00 PM
31.95
+0.16 (0.50%)
After-hours: Jun 24, 2022 6:28 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016201520142013
Revenue
194.75123.82.11000000
Revenue Growth (YoY)
57.31%5773.01%-------
Cost of Revenue
3.321.990.05000000
Gross Profit
191.43121.822.06000000
Selling, General & Admin
266.99210.85117.0951.4431.4420.969.673.862.31
Research & Development
212.14155.12174.56131.3187.8162.1636.6616.3212.86
Other Operating Expenses
0000000.070.330.5
Operating Expenses
479.12365.97291.64182.74119.2583.1346.3920.5115.66
Operating Income
-287.69-244.16-289.58-182.74-119.25-83.13-46.39-20.51-15.66
Interest Expense / Income
15.479.810.890.3500000
Other Expense / Income
-0.54-6.41-23.72-8.9-2.22-0.66-0.033.262.45
Pretax Income
-302.61-247.55-266.76-174.19-117.02-82.47-46.36-23.77-18.12
Income Tax
0.4800000000
Net Income
-303.09-247.55-266.77-174.19-117.02-82.47-46.36-23.77-18.12
Preferred Dividends
000000001.74
Net Income Common
-303.09-247.55-266.77-174.19-117.02-82.47-46.36-23.77-19.85
Shares Outstanding (Basic)
6361585142331321
Shares Outstanding (Diluted)
6361585142331321
Shares Change
2.66%5.17%14.02%20.86%27.45%159.30%665.07%36.06%-
EPS (Basic)
-4.81-4.04-4.57-3.41-2.76-2.48-3.95-14.20-16.14
EPS (Diluted)
-4.81-4.04-4.57-3.41-2.76-2.48-3.95-14.20-16.14
Free Cash Flow Per Share
-4.13-3.60-3.39-2.74-2.27-2.08-2.49-12.21-12.71
Gross Margin
98.30%98.40%97.72%------
Operating Margin
-147.72%-197.21%-13737.38%------
Profit Margin
-155.63%-199.96%-12654.93%------
Free Cash Flow Margin
-133.53%-178.20%-9384.82%------
Effective Tax Rate
-0.16%0.00%-0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBITDA
-278.53-226.92-255.94-169.24-115.37-81.31-45.49-23.11-17.58
EBITDA Margin
-143.02%-183.29%-12141.18%------
Depreciation & Amortization
8.6210.829.934.611.661.160.870.670.53
EBIT
-287.15-237.74-265.87-173.85-117.02-82.47-46.36-23.77-18.12
EBIT Margin
-147.44%-192.03%-12612.33%------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).